CoChat

Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations

Open access
Jackson, Daniel J., Bacharier, Leonard B., Mauger, David T., Boehmer, Susan, Beigelman, Avraham, Chmiel, James F., Fitzpatrick, Anne M., Gaffin, Jonathan M., Morgan, Wayne J., Peters, Stephen P., Phipatanakul, Wanda, Sheehan, William J., Cabana, Michael D., Holguin, Fernando, Martinez, Fernando D., Pongracic, Jacqueline A., Baxi, Sachin N., Benson, Mindy, Blake, Kathryn, Covar, Ronina, Gentile, Deborah A., Israel, Elliot, Krishnan, Jerry A., Kumar, Harsha V., Lang, Jason E., Lazarus, Stephen C., Lima, John J., Long, Dayna, Ly, Ngoc, Marbin, Jyothi, Moy, James N., Myers, Ross E., Olin, J. Tod, Raissy, Hengameh H., Robison, Rachel G., Ross, Kristie, Sorkness, Christine A., Lemanske, Robert F. · 2018 · New England Journal of Medicine
Cited by 143

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Asthma exacerbations occur frequently despite the regular use of asthma-controller therapies, such as inhaled glucocorticoids. Clinicians commonly increase the doses of inhaled glucocorticoids at early signs of loss of asthma control. However, data on the safety and efficacy of this strategy in children are limited. METHODS: We studied 254 children, 5 to 11 years of age, who had mild-to-moderate persistent asthma and had had at least one asthma exacerbation treated with systemic glucocorticoids in the previous year. Children were treated for 48 weeks with maintenance low-dose inhaled glucocorticoids (fluticasone propionate at a dose of 44 μg per inhalation, two inhalations twice daily) and were randomly assigned to either continue the same dose (low-dose group) or use a quintupled dose (high-dose group; fluticasone at a dose of 220 μg per inhalation, two inhalations twice daily) for 7 days at the early signs of loss of asthma control ("yellow zone"). Treatment was provided in a double-blind fashion. The primary outcome was the rate of severe asthma exacerbations treated with systemic glucocorticoids. RESULTS: The rate of severe asthma exacerbations treated with systemic glucocorticoids did not differ significantly between groups (0.48 exacerbations per year in the high-dose group and 0.37 exacerbations per year in the low-dose group; relative rate, 1.3; 95% confidence interval, 0.8 to 2.1; P=0.30). The time to the first exacerbation, the rate of treatment failure, symptom scores, and albuterol use during yellow-zone episodes did not differ significantly between groups. The total glucocorticoid exposure was 16% higher in the high-dose group than in the low-dose group. The difference in linear growth between the high-dose group and the low-dose group was -0.23 cm per year (P=0.06). CONCLUSIONS: In children with mild-to-moderate persistent asthma treated with daily inhaled glucocorticoids, quintupling the dose at the early signs of loss of asthma control did not reduce the rate of severe asthma exacerbations or improve other asthma outcomes and may be associated with diminished linear growth. (Funded by the National Heart, Lung, and Blood Institute; STICS ClinicalTrials.gov number, NCT02066129 .).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1710988

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 143

Metadata

Authors
Jackson, D. J., Bacharier, L. B., Mauger, D. T., Boehmer, S., Beigelman, A., Chmiel, J. F., Fitzpatrick, A. M., Gaffin, J. M., Morgan, W. J., Peters, S. P., Phipatanakul, W., Sheehan, W. J., Cabana, M. D., Holguin, F., Martinez, F. D., Pongracic, J. A., Baxi, S. N., Benson, M., Blake, K., Covar, R., Gentile, D. A., Israel, E., Krishnan, J. A., Kumar, H. V., Lang, J. E., Lazarus, S. C., Lima, J. J., Long, D., Ly, N., Marbin, J., Moy, J. N., Myers, R. E., Olin, J. T., Raissy, H. H., Robison, R. G., Ross, K., Sorkness, C. A., & Lemanske, R. F.
Venue
New England Journal of Medicine
Published
2018-03-08
Volume
378
Issue
10
Pages
891-901
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2793387368
Cited by
143
References
1
FWCI
15.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations. https://app.cochat.ai/papers/10.1056/nejmoa1710988
The paper
Jackson, D. J., Bacharier, L. B., Mauger, D. T., Boehmer, S., Beigelman, A., Chmiel, J. F., Fitzpatrick, A. M., Gaffin, J. M., Morgan, W. J., Peters, S. P., Phipatanakul, W., Sheehan, W. J., Cabana, M. D., Holguin, F., Martinez, F. D., Pongracic, J. A., Baxi, S. N., Benson, M., Blake, K., . . . Lemanske, R. F. (2018). Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1710988

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.